Sunday, February 25, 2018

Reversing Cancer: A Journey from Cancer to Cure


Reversing Cancer: A Journey from Cancer to Cure

 Paperback – April, 2004
by Gerald H. Smith (Author)

This book was borne out of a powerful personal journey involving the author’s wife being diagnosed with a stage III ovarian cancer. Faced with traditional medicine’s 14% to 20% treatment "success" rate, Dr. Smith was determined to reverse the "death" sentence imposed on his wife. By tracing the intelligent evolution of alternative cancer therapies, the author was able to formulate a treatment approach using alternative medicine integrated with conventional treatment. Doctor Smith’s 25 plus years of clinical experience with alternative approaches to healing guided him through numerous documents that provided the basis for his treatment protocol. The book provides an in-depth description of the effective, non-invasive advanced technologies that were used to build up his wife’s immune system and also destroy the ovarian cancer. The bonus of his research was two fold: First, it proved that the patient’s quality of life can be preserved even with use of chemo therapeutic agents and second, that the concepts discovered in solving his wife’s ovarian cancer can be applied to help reverse any type of cancer.

The contents focus on helping cancer patients and physicians define the underlying factors contributing to the cause of cancer and reasons for relapse. It also contributes new information on the key role mercury and dental infections play in the formation of cancer. The book also presents new technological advances to improve accuracy of selecting nutritional supplements. Another major find was Dr. Yoshiaki Omura’s advanced research, Selective Drug Uptake Enhancement Method, that targets affected areas with medications and nutrients by stimulating the appropriate acupuncture points.  The book offers an extensive resource for both cancer patients and physicians to guide them through the vast maze of alternative therapies. It also contains user-friendly inks to helpful websites to obtain essential products for the healing process. The information is also designed to empower cancer patients by teaching them how to remove toxic wastes, choose foods to regenerate and improve the immune system and use natural remedies to cope with the psychological component.  The reader is presented with Nobel Prize research that explains the true nature of cancer. The ultimate goal of this comprehensive book is to educate patients about the true nature of cancer in order to resolve their fears when being diagnosed with the big "C." The scientific model presented reveals the mechanism of cancer and gives patients the tools to assist in the reversing process. To convey all the above, the information was written in easy to understand language.

The Bi-Digital O-Ring Test performed by a licensed M.D., D.O., D.D.S., D.M.D., L.Ac., or O.M.D. trained by Dr. Yoshiaki Omura, M.D., Sc.D., is an early non-invasive diagnostic test for intractable medical problems with their safe and effective treatment. It can involve the detection and treatment of early stages of cardiovascular disease, Alzheimer's disease, Autism, and cancer (often long before any known laboratory test can detect any abnormality or malignancy). It may be the ultimate in preventive medicine available today. BDORT evaluation can diagnose many medical problems early, and can also help manage conditions such as malignant tumors, chronic severe pain, cardiovascular diseases, Alzheimer's disease, Autism and neuromuscular diseases.
This method can save and prolong lives, because of effective medicines can be determined and administered quickly. By the "Selective Drug Uptake Enhancement Method", developed by Dr. Omura, most of the effective medication can be delivered selectively to the pathological areas, reducing the drug going to normal tissue and thus minimizing side effects. Such precise, non-toxic, effective treatment customized to each individual can achieve amazing results in hours or days depending on the pathogenic factors unique to each individual.
Through virtual drug testing, by Omura's Bi-Digital O-Ring Test, harmful drug interactions among multiple beneficial drugs (taken together), allergies, and toxic doses can be detected and
avoided before administration.
Screening:
Most of the cancer & other malignancies can be screened in 5 minutes & after that the pathological diagnosis takes an additional 10 – 20 minutes for each malignancy.
Treatment:
Safe & effective treatment can be selected for each medical problem. For the cancer treatment increasing the normal cell telomere & or increasing longevity gene significantly can reduce cancer cell telomeres to practically zero & can inhibit cancer cellular activities safely & effectively & non-invasively.
Optimal Dose of Medicine:
In treating with any medicine, optimal dose is most important. If overdose is given, instead of improvement, the opposite effect will take place. Dr Omura will demonstrate all this during the meeting using participants. Many patients die from overdose of chemotherapy. An overdose of chemotherapy promotes the growth of cancer.
Acupuncture Point Localization & Stimulation:
Dr Omura will also discuss a simple method of stimulating a most important acupuncture point True ST 36 which increases normal cell telomere & longevity gene. His Bi-Digital O-Ring Test is the only method that can localize the exact location, shape, size & depth of the acupuncture point as well as the neurotransmitters inside the acupuncture point all non-invasively.
This is a rare opportunity to study with the Founder of the Bi-Digital O-Ring Test who performed the first acupuncture anesthesia outside of China for a surgical procedure in 1972 in New York University Hospital of Albert Einstein College of Medicine at .

EXAMPLES OF HOW BDORT MAY BE APPLIED:
- Diagnosis
- Treatment
- Material Evaluation
- Optimal Dosing
- Electromagnetic Field Effects
- Environmental Toxin Evaluation
- Selective Drug Uptake Enhancement
- Acupuncture Point Localization
- Meridian Location
- Shape, Diameter, and Depth of acupuncture points


CEREBROPHYSIOLOGICAL RESPONSE MECHANISM IN BI-DIGITAL O-RING TEST BY FREQUENCY ANALYSIS OF HUMAN BRAIN WAVES - EFFECT OF CHEMICAL SUBSTANCES
Noriyuki Tani D.D.S., Shigeyuki Tanaka, Masaru Ono and Yoshihiro Yagyu First Department of Prosthodontics Meikai University School of Dentistry 1-1, Keyakidai, Sakado-shi, Saitama Prefecture
 
ABSTRACT
The Bi-Digital O-Ring test (O-ring test) developed in 1978 by Y. Omura as a new diagnostic approach has gained a wide-spread recognition in many countries of the world as a clinically useful test. In spite of and contrary to the simplicity of its procedure, its mechanism has remained largely unknown. It is especially obscure what cerebro-physiological changes are induced or how sensitive the cerebral recognition level is. In other words, since a stimulant applied in the O-ring test or given by a chemical substance produces very feeble stimulation, it still remains unknown whether the reaction occurring in the O-ring test is identical to the conventionally-defined cerebral evoked response or whether the reaction is induced through a completely different response mechanism. To determine the mechanism on a cerebro-physiologial level, it is necessary to define the potentiality of this test as a human cerebral sensor as so described in 1965 by Tsunoda and in 1986 by Kikuchi et al. Our presentation at the Third International Symposium on Acupuncture and Elerctro-Therapeutics has confirmed the potentiality of the O-ring test as a human cerebral sensor, because the reaction could be recognized as a cerebral response to weak light of 80 luxs. This study was undertaken to further confirm our previous results. Experiment was carried out using the same experimental system as in our previous study presented at the symposium to confirm the existence of cerebral responses to non-contact stimulation with chemical substances delivered at a distance of 1 or 15cm from the stimulation points at the regions of the oral cavity and stomach in 10 subjects. The chemical substances used as stimuli consisted of potassium cyanide, arsenic, paraformaldehyde, methyl methacrylate monomer, vitamin C and toothpaste. The following results were obtained:
1. When stimulated by a conventional manner of stimulation, cerebral evoked potential tended to appear acutely at stimulation. In the O-ring test with chemical substances, the appearance of the response (integration of 10-second values )tended to be suppressed.
2. The cerebral responses produced by stimulation of the oral cavity and stomach in a resting state with closed eyes were not symmetrical over both sides. Especially at the d, ?, a and ß1 regions, the responses were dominant on the right temporal and left occipital areas. This finding does not agree with the earlier described symmetry of the cerebral response.
3. The characteristic finding in this experiment was the left-hemispheric dominance at the ß2 region unlike the right-hemispheric dominance at other regions.
4. A distinct difference was found between the responses by stimulation with harmful substances and those by stimulation with harmless substances. However, there were no substance-related differences between the group of harmful substances and that of harmless substances.
5. Distance-related differences were demonstrated in the intensity of cerebral responses. Stimulation at a distance of 1cm frontally to the oral cavity induced strong cerebral responses to methyl methacrylate monomer, vitamin C and toothpaste.
6. In stimulation with potassium cyanide, arsenic and paraformaldehyde, the difference in distance produced no differences in the intensity of responses. It is considered that since the both substance groups induced cerebral responses at either distance as described in 4, potassium cyanide, arsenic and paraformaldehyde induced cerebral responses to almost the same degree at either distance, which accounts for the lack of significant differences.
 
Dr. Yoshiaki Omura, MD is general practitioner and Cardiologist of more than 50 years of experience. He is also the president and founder of the International College of Acupunc-ture & Electro-Therapeutics, president and founder of the International Bi-Digital O-Ring Test Medical Association, and medical research director of the Heart Disease Research Foundation
Highlights of his contributions include:
 
· Director of Medical Research, Heart Disease Research Foundation, New York
 
· President, International College of Acupuncture and Electro-Therapeutics, New York
 
· Adjunct Prof. Dept. of Community and Preventive Medicine, New York Medical College, New York
 
· Prof., Non-Orthodox Medicine Dept., Ukrainian National Medical University, Kiev, Ukraine
 
· Former Visiting Research Prof., Dept. of Electrical Engineering, Manhattan College, New York
 
. Former Adjunct Prof. of Pharmacology, Chicago Medical School
 
· Former Adjunct Prof. of Physiology, Showa University of Medicine, Tokyo, Japan
 
· Founder and Editor-in-Chief, Acupuncture & Electro-Therapeutics Research, The International Journal
 
· President, Japan Bi-Digital O-Ring Test Association
 
· Former Attending Physician, Neuroscience Dept., New York Pain Center, Long Island College Hospital
 
· Former Consultant, New York Pain Center, Long Island College Hospital
 
Doctor of medicine - Medical School - Yokohama City University 1958
 
 


LIFE FELLOW OF THE ROYAL SOCIETY OF MEDICINE (LONDON, ENGLAND)

FELLOW PRESIDENT INTERNATIONAL COLLEGE OF ACUPUNTURE AND ELECTRO-PHARAPEUTICS

LIFE FELLOW, AMERICAN COLLEGE OF ACUPUNCTURE

LIFE FELLOW OF THE ROYAL SOCIETY OF MEDICINE (LONDON, ENGLAND)

LIFE FELLOW, DIPLOMATE AND EXECUTIVE MEMBER AMERICAN ASSOCIATION OF INTEGRATIVE MEDICINE

FELLOW PRESIDENT INTERNATIONAL COLLEGE OF ACUPUNTURE AND ELECTRO-PHARAPEUTICS

LIFE FELLOW, AMERICAN COLLEGE OF ACUPUNCTURE

LIFE FELLOW, DIPLOMATE AND EXECUTIVE MEMBER AMERICAN ASSOCIATION OF INTEGRATIVE MEDICINE

DIPLOMAT OF THE AMERICAN ACADEMY OF THE PAIN MANAGEMENT

FELLOW AND PRESIDENT OF THE INTERNATIONAL COLLEGE OF ACUPUNTURE AND ELECTRO-THERAPEUTICS

LIFE FELLOW, DIPLOMATE OF THE AMERICAN ASSOCIATION OF INTEGRATIVE MEDICINE
 
 
 
 

No comments: